The application of prescribing indicators to a primary care prescription database in Ireland

David Williams, Kenneth Arthur Bennett, J. Feely

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To develop appropriate prescribing indicators and apply these to Irish prescription data.

Methods: A postal survey of 145 randomly selected general practitioners working within the Eastern Health Board region of the State-supported General Medical Services scheme in Ireland regarding the applicability of selected prescribing indicators was carried out. Such indicators were then applied to aggregate prescription data.

Results: Prescribing indicators based on agents of questionable efficacy/poor quality prescribing and those based on good prescribing practice were thought to make suitable indicators. Low rates of prescribing were noted for indicators based on drugs of limited efficacy, e. g. cerebral and peripheral vasodilators ( rate 3.1 per 1,000 prescriptions), whilst indicators based on drugs associated with good prescribing practice were associated with higher prescribing rates, e. g. the prescription of aspirin in patients receiving nitrate therapy( rate 7.13 per 1,000 patients). However, a low rate of generic prescribing (4.6%) was found amongst general practitioners in the study. The largest variability in prescribing was seen with the prescribing of peripheral and cerebral vasodilators ( 75th/ 25th centile= 5.6) and the prescription of long-acting sulphonylureas ( 75th/ 25th centile= 66.6).

Conclusions: Quality indicators based on aggregate prescribing provide valuable information on prescribing standards and should be developed with the close involvement of prescribers.

Original languageEnglish
Pages (from-to)127-134
Number of pages7
JournalEuropean Journal of Clinical Pharmacology
Volume61
Issue number2
DOIs
Publication statusPublished - 2005

Keywords

  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • GENERAL-PRACTICE
  • PRACTITIONERS
  • FEEDBACK
  • PERFORMANCE
  • DISEASE
  • QUALITY
  • ENGLAND
  • TRIAL

Cite this

The application of prescribing indicators to a primary care prescription database in Ireland. / Williams, David; Bennett, Kenneth Arthur; Feely, J.

In: European Journal of Clinical Pharmacology, Vol. 61, No. 2, 2005, p. 127-134.

Research output: Contribution to journalArticle

Williams, David ; Bennett, Kenneth Arthur ; Feely, J. / The application of prescribing indicators to a primary care prescription database in Ireland. In: European Journal of Clinical Pharmacology. 2005 ; Vol. 61, No. 2. pp. 127-134.
@article{04276a521d9e4a24aae85e6112a1c19c,
title = "The application of prescribing indicators to a primary care prescription database in Ireland",
abstract = "Objective: To develop appropriate prescribing indicators and apply these to Irish prescription data.Methods: A postal survey of 145 randomly selected general practitioners working within the Eastern Health Board region of the State-supported General Medical Services scheme in Ireland regarding the applicability of selected prescribing indicators was carried out. Such indicators were then applied to aggregate prescription data.Results: Prescribing indicators based on agents of questionable efficacy/poor quality prescribing and those based on good prescribing practice were thought to make suitable indicators. Low rates of prescribing were noted for indicators based on drugs of limited efficacy, e. g. cerebral and peripheral vasodilators ( rate 3.1 per 1,000 prescriptions), whilst indicators based on drugs associated with good prescribing practice were associated with higher prescribing rates, e. g. the prescription of aspirin in patients receiving nitrate therapy( rate 7.13 per 1,000 patients). However, a low rate of generic prescribing (4.6{\%}) was found amongst general practitioners in the study. The largest variability in prescribing was seen with the prescribing of peripheral and cerebral vasodilators ( 75th/ 25th centile= 5.6) and the prescription of long-acting sulphonylureas ( 75th/ 25th centile= 66.6).Conclusions: Quality indicators based on aggregate prescribing provide valuable information on prescribing standards and should be developed with the close involvement of prescribers.",
keywords = "NONSTEROIDAL ANTIINFLAMMATORY DRUGS, GENERAL-PRACTICE, PRACTITIONERS, FEEDBACK, PERFORMANCE, DISEASE, QUALITY, ENGLAND, TRIAL",
author = "David Williams and Bennett, {Kenneth Arthur} and J. Feely",
year = "2005",
doi = "10.1007/s00228-004-0876-3",
language = "English",
volume = "61",
pages = "127--134",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - The application of prescribing indicators to a primary care prescription database in Ireland

AU - Williams, David

AU - Bennett, Kenneth Arthur

AU - Feely, J.

PY - 2005

Y1 - 2005

N2 - Objective: To develop appropriate prescribing indicators and apply these to Irish prescription data.Methods: A postal survey of 145 randomly selected general practitioners working within the Eastern Health Board region of the State-supported General Medical Services scheme in Ireland regarding the applicability of selected prescribing indicators was carried out. Such indicators were then applied to aggregate prescription data.Results: Prescribing indicators based on agents of questionable efficacy/poor quality prescribing and those based on good prescribing practice were thought to make suitable indicators. Low rates of prescribing were noted for indicators based on drugs of limited efficacy, e. g. cerebral and peripheral vasodilators ( rate 3.1 per 1,000 prescriptions), whilst indicators based on drugs associated with good prescribing practice were associated with higher prescribing rates, e. g. the prescription of aspirin in patients receiving nitrate therapy( rate 7.13 per 1,000 patients). However, a low rate of generic prescribing (4.6%) was found amongst general practitioners in the study. The largest variability in prescribing was seen with the prescribing of peripheral and cerebral vasodilators ( 75th/ 25th centile= 5.6) and the prescription of long-acting sulphonylureas ( 75th/ 25th centile= 66.6).Conclusions: Quality indicators based on aggregate prescribing provide valuable information on prescribing standards and should be developed with the close involvement of prescribers.

AB - Objective: To develop appropriate prescribing indicators and apply these to Irish prescription data.Methods: A postal survey of 145 randomly selected general practitioners working within the Eastern Health Board region of the State-supported General Medical Services scheme in Ireland regarding the applicability of selected prescribing indicators was carried out. Such indicators were then applied to aggregate prescription data.Results: Prescribing indicators based on agents of questionable efficacy/poor quality prescribing and those based on good prescribing practice were thought to make suitable indicators. Low rates of prescribing were noted for indicators based on drugs of limited efficacy, e. g. cerebral and peripheral vasodilators ( rate 3.1 per 1,000 prescriptions), whilst indicators based on drugs associated with good prescribing practice were associated with higher prescribing rates, e. g. the prescription of aspirin in patients receiving nitrate therapy( rate 7.13 per 1,000 patients). However, a low rate of generic prescribing (4.6%) was found amongst general practitioners in the study. The largest variability in prescribing was seen with the prescribing of peripheral and cerebral vasodilators ( 75th/ 25th centile= 5.6) and the prescription of long-acting sulphonylureas ( 75th/ 25th centile= 66.6).Conclusions: Quality indicators based on aggregate prescribing provide valuable information on prescribing standards and should be developed with the close involvement of prescribers.

KW - NONSTEROIDAL ANTIINFLAMMATORY DRUGS

KW - GENERAL-PRACTICE

KW - PRACTITIONERS

KW - FEEDBACK

KW - PERFORMANCE

KW - DISEASE

KW - QUALITY

KW - ENGLAND

KW - TRIAL

U2 - 10.1007/s00228-004-0876-3

DO - 10.1007/s00228-004-0876-3

M3 - Article

VL - 61

SP - 127

EP - 134

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 2

ER -